FDA Brief

Company record

Padagis US LLC

0 FDA warning letters since 2023 and 1 recall in the last 12 months.

Get an email the day FDA posts anything new about Padagis US LLC.

Recalls

ReportedClassFirmProduct and reason
Jul 22 Class II Padagis US LLC
Drug
Nystatin Cream USP, (100,000 USP Nystatin Units), NET WT 15 g, Rx only, 15 g tube, Manufactured by Padagis, Yeruham, Israel, NDC 45802-059-35
Subpotent Drug: Low out of specification assay results performed during long-term stability testing.